Outcome achieved.
The market might want to see a first quarter of Adheris revenue under MDR before the share price lifts.
- Raising approximately AUD $35 million, exceeding the minimum required to complete the acquisition of Adheris Health.
- Adheris’ strong sales pipeline of health programs relating to pharmaceuticals and vaccines built this quarter provides confidence for FY21 sales growth.
- Major shareholder HMS and a number MedAdvisor directors have participated in the round.
Ann: MDR successfully completes Placement & Institutional Offer, page-2
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 49.5¢ | 48.0¢ | $172.4K | 357.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32350 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 4550 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| MDR (ASX) Chart |